It's crystal clear how you are trying to downramp this stock for a lower reentry. I suggest you offer something meaningful in the way of figures or valuations or just stop downramping.
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil